Navigation Links
Haag-Streit USA and Optovue Team Up to Introduce Octopus/Optovue Bundle
Date:4/26/2013

MASON, Ohio, April 26, 2013 /PRNewswire-iReach/ -- Haag-Streit USA and Optovue have joined forces to bundle Haag-Streit's Octopus perimeter with Optovue's Optical Coherence Tomography (OCT) technology.  The combined Octopus/OCT offering will be distributed by Optovue in the United States.

"Haag-Streit is happy to partner with Optovue for its leadership in OCT technology and outstanding customer service. Our bundled technologies will create an advanced package that will provide a superior diagnostic tool to the ophthalmic industry," said Ernest Cavin , president and chief executive officer of Haag-Streit USA.

"The OCT technology provided by the RTVue and iVue combined with the functional testing from the Octopus will be the best of both worlds, offering the optimum structure-function solution," said Jay Wei , Founder and CEO of Optovue.

Optovue will be responsible for sales, installation and training of Octopus in the United States and Haag-Streit will be responsible for ongoing clinical support and technical service.

About the Octopus 900®

The roots of Octopus date back to the 1970s. The Octopus 900 represents the most complete 90-degree full-field projection perimeter available today for private practices, clinics, teaching institutions and scientific applications. It allows for testing in all levels of disease – from early detection, tracking progression or performing the most sensitive examinations at the end stage of disease.

About RTVue® and iVue®

RTVue was the first FDA cleared Fourier domain (also known as spectral domain) OCT launched in the United States, and also the first OCT cleared by the U.S. Food and Drug Administration for both corneal and retinal imaging. The iVue is the compact Fourier domain version of the RTVue OCT, offering the same scanning speed and resolution as the larger system, that includes scanning and reports for retina, retina nerve fiber and cornea assessment by the clinician.

About Haag-Streit

Headquartered in Bern, Switzerland, with its U.S. headquarters in Mason, Ohio, Haag-Streit manufactures leading optical instruments for ophthalmologists and optometrists. Since 1858 the Haag-Streit slit lamp has been regarded as the standard instrument for ophthalmic diagnosis.  Anticipating technological trends, Haag-Streit has developed the most advanced perimeter available today and is setting the pace in biometry with the Lenstar® optical biometer. For more information, visit www.haag-streit-usa.com

About Optovue

Optovue Inc. is a privately held ophthalmic device company dedicated to working with eye care professionals and clinical researchers to lead the commercialization of new imaging modalities that improve diagnosis and therapy of ocular disease. Optovue has achieved widespread market success through a combination of unique data analysis design, a reputation for excellent customer service, and rapid innovation of its technology in response to physician feedback. The company is headquartered in Fremont, CA, with operations in Carlsbad, CA and European operations in Dossenheim, Germany. For more information, visit www.optovue.com

NOTE TO EDITORS: Spokespeople available for comment. Photos available.

Media Contact: Ben Singleton , Ideopia, 513.947.1444 ext 18, bens@ideopia.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE Haag-Streit USA; Optovue Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology news :

1. EyeLock Inc. Introduces EyeSwipe Nano TS Iris Scanning Turnstile Solution for Secure Access Control
2. Ukraine to Introduce European Standard of Biometric ID
3. BioFortis Inc., Introduces Next Generation Biobanking Software Platform for Biomarker-Based Clinical Research
4. TI introduces an all-in-one enterprise tablet solution for less than $70 total BOM
5. Integrated Biometrics Introduces Sherlock The Worlds Lightest, Thinnest, Smallest, Appendix F Mobile ID Fingerprint Sensors
6. Website for new open-access journal, eLife, introduced today
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2016)... SAN FRANCISCO and WARSAW, Poland , Nov. 30, 2016 ... sleeping. It is one of the most crucial aspects of recovery so we need ... host of serious health risks, including heart problems, high blood pressure, stroke, diabetes, and ... family and friends sleep and find a Christmas present that could help them to ... ...
(Date:11/29/2016)... Lithuania , Nov. 29, 2016 /PRNewswire/ ... biometric identification and object recognition technologies, today ... (SDK) for fingerprint recognition solutions that run ... a fingerprint template using less than 128KB ... in compact devices that have limited on-board ...
(Date:11/24/2016)... Cercacor today introduced Ember TM Sport ... non-invasively measure hemoglobin, Oxygen Content, Oxygen Saturation, Perfusion ... in approximately 30 seconds. Smaller than a smartphone, using ... to key data about their bodies to help monitor ... Hemoglobin carries oxygen to muscles. When hemoglobin ...
Breaking Biology News(10 mins):
(Date:12/5/2016)... ... 05, 2016 , ... This composition patent, U.S. Patent No. ... The composition claims are not limited to any particular process to make or ... carbon fibers, graphene, and other materials. A continuation application, U.S. Patent App. ...
(Date:12/5/2016)... , Dec. 5, 2016  Renova™ Therapeutics, ... congestive heart failure and other chronic diseases, announced ... the company as Chief Financial Officer (CFO), effective ... with 20 years of experience in financial management ... biotech and software companies. Most recently, Ms. Bovenizer ...
(Date:12/5/2016)... , December 5, 2016 The ... with almost $108 billion of revenue and some $890 ... were spent on global biopharmaceuticals, and this figure is ... Stock-Callers.com has lined up these four equities for assessment: ... Pharmaceuticals Inc. (NASDAQ: ACAD ), Acorda Therapeutics ...
(Date:12/2/2016)... ... ... In anticipation of AxioMed’s exclusive cleanroom manufacturing facility in ... Lubinski will be traveling to Switzerland from December 5-10. Mr. Lubinski will meet ... to discuss the benefits of a viscoelastic disc. AxioMed received CE mark in ...
Breaking Biology Technology: